Cholera toxin is the principal virulence factor of Vibrio cholerae, the Gram-negative bacterium that causes the severe diarrheal disease cholera. The investigators recently discovered that this potent enterotoxin is encoded by a novel filamentous bacteriophage designated CTX. The CTX phage is the first filamentous phage known to result in the lysogenic conversion of a host bacterium. The CTX phage can integrate into the V. cholerae chromosome and form stable lysogens or, after induction, excise from the chromosome and replicate as a plasmid. During this replicative stage of the phage life-cycle, cholera toxin can be expressed independently of the factors which were believed to be essential for its expression. Our demonstration of the induction of CTX phage from V. cholerae lysogens within the host gastrointestinal tract suggests the possibility that in vivo CTX phage induction plays a significant role in the virulence of V. cholerae. The objectives of the proposed studies are to understand the life-cycle of the CTX phage at the molecular level and to assess the significance of this bacteriophage in the pathogenesis of cholera. These studies will establish the molecular biology of a mechanism of horizontal transfer of virulence genes and thereby further our understanding of the emergence of pathogens. The study of the intraintestinal induction of CTX phage from lysogens, could establish a new paradigm for understanding the regulation of the expression of phage encoded virulence factors in a variety of bacterial pathogens that are lysogenized with converting phage. This work will also have important ramifications for the design of safer live attenuated V. cholerae vaccine strains.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042347-05
Application #
6488698
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Hall, Robert H
Project Start
1998-01-01
Project End
2002-12-31
Budget Start
2002-01-01
Budget End
2002-12-31
Support Year
5
Fiscal Year
2002
Total Cost
$267,303
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Weaver, Anna I; Murphy, Shannon G; Umans, Benjamin D et al. (2018) Genetic Determinants of Penicillin Tolerance in Vibrio cholerae. Antimicrob Agents Chemother 62:
Yin, Kaiyu; Guan, Yunpeng; Ma, Ruiqing et al. (2018) Critical role for a promoter discriminator in RpoS control of virulence in Edwardsiella piscicida. PLoS Pathog 14:e1007272
Pacheco, Alline R; Lazarus, Jacob E; Sit, Brandon et al. (2018) CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection. MBio 9:
Chao, Michael C; Abel, Sören; Davis, Brigid M et al. (2016) The design and analysis of transposon insertion sequencing experiments. Nat Rev Microbiol 14:119-28
Dörr, Tobias; Lam, Hubert; Alvarez, Laura et al. (2014) A novel peptidoglycan binding protein crucial for PBP1A-mediated cell wall biogenesis in Vibrio cholerae. PLoS Genet 10:e1004433
Lu, Xi; Skurnik, David; Pozzi, Clarissa et al. (2014) A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli. MBio 5:e00974-14
Pacheco, Alline R; Curtis, Meredith M; Ritchie, Jennifer M et al. (2012) Fucose sensing regulates bacterial intestinal colonization. Nature 492:113-7
Chin, Chen-Shan; Sorenson, Jon; Harris, Jason B et al. (2011) The origin of the Haitian cholera outbreak strain. N Engl J Med 364:33-42
Waldor, Matthew K; Hotez, Peter J; Clemens, John D (2010) A national cholera vaccine stockpile--a new humanitarian and diplomatic resource. N Engl J Med 363:2279-82
Kimsey, Harvey H; Waldor, Matthew K (2009) Vibrio cholerae LexA coordinates CTX prophage gene expression. J Bacteriol 191:6788-95

Showing the most recent 10 out of 71 publications